In a notable move that reinforces its position as an innovator in the medical cannabis sector, Ethos Cannabis has officially launched a new line of infused live resin flower in Pennsylvania under its Natural Selections brand. Known as “Aurora,” the product line debuted in March 2025 and is now available exclusively at Ethos dispensary locations throughout the state.

Aurora introduces a premium cannabis experience that marries expertly hand-trimmed flower with a generous coating of strain-specific live resin. This approach is designed to amplify both the flavor and potency of each product, meeting the evolving expectations of Pennsylvania’s growing medical cannabis community.

The timing of the launch was strategic. Aurora’s release was highlighted during the 2025 Pennsylvania Cannabis Convention (PACC), where Ethos served as the title sponsor. Held in Philadelphia, the convention provided an ideal platform for Ethos to showcase Aurora to industry professionals, patients, and advocates alike. Through various on-site activations, educational panels, and product displays, Ethos leveraged the event to introduce Aurora to a wider audience while reaffirming its role as a thought leader within the state’s cannabis ecosystem.

The Aurora line features five distinct strains, each carefully selected to deliver unique effects and rich terpene profiles:

• Tropicana C x Cranberry Z (Sativa): A bright and citrus-heavy strain designed for daytime use, offering a refreshing, energetic boost.
• OG Bloobs x Key Lime Kush (Indica): A calming, full-body option with earthy and lime undertones, ideal for evening relaxation.
• Dosidos x Mallow OG (Indica): Known for its nutty, earthy flavor and sedating qualities, this blend is perfect for winding down.
• Black Maple x Pura Vida (Hybrid): A balanced hybrid offering a smooth, citrus-driven profile with hints of forest floor.
• Cranberry Z x Dulce De Uva (Hybrid): A fruit-forward blend with bold grape flavors and a lively terpene presence that enhances mood and flavor alike.

Each strain in the Aurora lineup is crafted with meticulous attention to detail, reflecting Ethos Cannabis’ deep commitment to quality, consistency, and patient satisfaction. According to Steve Garner, Vice President of Cultivation at Ethos, the new line represents a culmination of years of experience and a desire to bring something truly exceptional to market. “Aurora takes our premium hand-trimmed flower and elevates it with a rich coating of strain-specific live resin, reflecting Natural Selections’ commitment to craft-level quality at scale,” he said during the product unveiling.

Ethos Cannabis’ decision to sponsor the 2025 Pennsylvania Cannabis Convention and launch Aurora simultaneously demonstrates a broader vision. Beyond product innovation, the company aims to promote education, equity, and progress within the cannabis space. During the convention, Ethos team members led discussions on key issues such as patient access, regulatory evolution, and inclusive business practices—further solidifying the brand’s role as a responsible and engaged industry stakeholder.

As the Pennsylvania cannabis market continues to grow, offerings like Aurora stand out for their ability to meet elevated consumer expectations. Ethos’ launch of this infused flower line marks a significant step forward, signaling that the future of cannabis in the Commonwealth will be defined by bold flavors, high potency, and a steadfast dedication to quality.